These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8725869)

  • 1. Proinsulin secretion during the first 3 years after diagnosis in diabetic patients with and without islet cell antibodies.
    Gottsäter A; Owens DR; Luzio S; Sundkvist G
    Diabetes Care; 1996 Jun; 19(6):659-62. PubMed ID: 8725869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
    Li YB; Zhu DL; Tian HM; Shi LX; Luo ZJ; Yan L; Zeng LY; Zhou ZG; Yang LY; Liu J; Li M; Weng JP
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2537-41. PubMed ID: 17198561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
    Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstom RW; Fujimoto WY
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S63-6. PubMed ID: 8894485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Røder ME; Porte D; Schwartz RS; Kahn SE
    J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
    Prigeon RL; Jacobson RK; Porte D; Kahn SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?
    Bano G; Rodin DA; White A; O'Rahilly S; Nussey SS
    Diabet Med; 2001 Jan; 18(1):17-21. PubMed ID: 11168336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus.
    Davies MJ; Metcalfe J; Gray IP; Day JL; Hales CN
    Diabet Med; 1993 May; 10(4):305-12. PubMed ID: 8508611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content.
    Cooper MB; Tan KC; Hales CN; Betteridge DJ
    Diabet Med; 1996 Sep; 13(9):816-27. PubMed ID: 8891457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
    Røder ME; Dinesen B; Hartling SG; Houssa P; Vestergaard H; Sodoyez-Goffaux F; Binder C
    Diabetes Care; 1999 Apr; 22(4):609-14. PubMed ID: 10189540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance.
    Shimizu M; Kawazu S; Tomono S; Ohno T; Utsugi T; Kato N; Ishi C; Ito Y; Murata K
    Diabetes Care; 1996 Jan; 19(1):8-11. PubMed ID: 8720525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
    Kahn SE; Halban PA
    Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitus.
    Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
    Diabet Med; 1994; 11(1):71-8. PubMed ID: 8181257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients.
    Coifman R; Dalbosco IS; Russo EM; Moisés RS
    Braz J Med Biol Res; 1999 Jan; 32(1):67-72. PubMed ID: 10347771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet cell antibodies at diagnosis, but not leanness, relate to a better cardiovascular risk factor profile 5 years after diagnosis of NIDDM.
    Gottsäter A; Ahmed M; Lilja B; Fernlund P; Sundkvist G
    Diabetes Care; 1996 Jan; 19(1):60-3. PubMed ID: 8720536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
    Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
    Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.